Completion rates of adjuvant chemotherapy for colon cancer: A historical perspective

Journal of the National Cancer Institute

Volumn 98, Issue 9, 2006, Pages 570-571

  Grann, Victor R ^a   Muggia, Franco M ^b  

^a Columbia University ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; LEVAMISOLE; OXALIPLATIN;

AGE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLON RESECTION; COMORBIDITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; ETHNIC DIFFERENCE; FUNCTIONAL STATUS; HUMAN; INCOME; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MEDICARE; OVERALL SURVIVAL; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; READING; SEX DIFFERENCE; SOCIAL SUPPORT; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; AGED; COLON TUMOR; EPIDEMIOLOGY; FRAIL ELDERLY; MORTALITY; NOTE; RISK FACTOR; STATISTICS; UNITED STATES;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FRAIL ELDERLY; HUMANS; MEDICARE; PATIENT COMPLIANCE; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SOCIAL SUPPORT; UNITED STATES;

EID: 33646456787     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj184     Document Type: Editorial

References (15)

1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92.
2. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 1995; 122:321-6.
3. O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998;16:295-300.
4. Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: Final report of Intergroup 0089. J Clin Oncol 2005;23:8671-8.
5. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004;22: 1797-806.
6. Dobie SA, Baldwin L-M, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by medicare patients with stage III colon cancer. J Natl Cancer Inst 2006;98:610-9.
7. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
8. Potosky AL, Warren JL, Riedel ER, Klabunde CN, Earle CC, Begg CB. Measuring complications of cancer treatment using the SEER-Medicare data. Med Care 2002;40(8 Suppl):IV-62-8.
9. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97: 1407-27.
10. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
11. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989;7:1447-56.
12. Cancer Trends Progress Report - 2005 Update, National Cancer Institute, NIH, DHHS, Bethesda, MD, December 2005. Available at http://Progressreport.cancer.gov.
13. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon cancer. N Engl J Med 1990;322:352-8.
14. Mayer RJ. Does adjuvant therapy work in colon cancer? N Engl J Med 1990;322:399-401.
15. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.